Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer

Cancer Letters

Volumn 168, Issue 1, 2001, Pages 31-36

  Menin, C ^a   Banna, G L ^a   De Salvo, G ^a   Lazzarotto, V ^a   De Nicolo, A ^a   Agata, S ^a   Montagna, M ^a   Sordi, G ^a   Nicoletto, O ^a   Chieco Bianchi, L ^a   D'Andrea, E ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Androgen receptor; CAG polymorphism; Genetic predisposition; Hereditary breast ovarian cancer risk; Modifier genes

Indexed keywords

ANDROGEN RECEPTOR; NUCLEOTIDE;

ALLELE; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; ONCOGENE; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL;

ALLELES; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENOTYPE; HUMANS; MUTATION; OVARIAN NEOPLASMS; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS;

EID: 0035838595     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00473-6     Document Type: Article

References (16)

1. Easton D., Peto J. The contribution of inherited predisposition to cancer incidence. Cancer Surv. 9:1990;395-416.
2. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D.T., Weber B., Lenoir G., Chang-Claude J., Sobol H., Teare M.D., Struewing J., Arason A., Scherneck S., Peto J., Rebbeck T.R., Tonin P., Neuhausen S., Barkardottir R., Eyfjord J., Lynch H., Ponder B.A.J., Gayther S.A., Birch J.M., Lindblom A., Stoppa-Lyonnet D., Bignon Y., Borg A., Hamann U., Haites N., Scott R.J., Maugard C.M., Vasen H., Seitz S., Cannon-Albright L.A., Schofield A., Zelada-Hedman M. the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families, Am. J. Hum. Genet. 62:1998;676-689.
3. Rahman N., Stratton M.R. The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32:1998;95-121.
4. Birrell S.N., Hall R.E., Tilley W.D. Role of the androgen receptor in human breast cancer. J. Mammary Gland Biol. Neoplasia. 3:1998;95-103.
5. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. 90:1998;1774-1786.
6. Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186.
7. Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Dahl D., Brufsky A., Talcott J., Hennekens C.H., Kantoff P.W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer (published erratum appears in Proc. Natl. Acad. Sci USA 1997 Jul 22;94(15):8272). Proc. Natl. Acad. Sci. U S A. 94:1997;3320-3323.
8. Spurdle A.B., Webb P.M., Chen X., Martin N.G., Giles G.G., Hopper J.L., Chenevix-Trench G. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. Int. J. Cancer. 87:2000;637-643.
9. Yu H., Bharaj B., Vassilikos E.J., Giai M., Diamandis E.P. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res. Treat. 59:2000;153-161.
10. Spurdle A.B., Dite G.S., Chen X., Mayne C.J., Southey M.C., Batten L.E., Chy H., Trute L., McCredie M.R., Giles G.G., Armes J., Venter D.J., Hopper J.L., Chenevix-Trench G. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J. Natl. Cancer Inst. 91:1999;961-966.
11. Given H.F., Radbourne R., Oag H., Merritt S., Barclay E., Hanby A.M., Lamlum H., McGrath J., Curran C., Tomlinson I.P. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur. J. Cancer. 36:2000;533-534.
12. Rebbeck T.R., Kantoff P.W., Krithivas K., Neuhausen S., Blackwood M.A., Godwin A.K., Daly M.B., Narod S.A., Garber J.E., Lynch H.T., Weber B.L., Brown M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am. J. Hum. Genet. 64:1999;1371-1377.
13. Federico M., Maiorana A., Mangone L., Turchetti D., Canossi B., Cortesi L., Romagnoli R., Silingardi V. Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. Breast Cancer Res. Treat. 55:1999;213-221.
14. Montagna M., Santacatterina M., Corneo B., Menin C., Serova O., Lenoir G.M., Chieco-Bianchi L., D'Andrea E. Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res. 56:1996;5466-5469.
15. Montagna M., Santacatterina M., Torri A., Menin C., Zullato D., Chieco-Bianchi L., D'Andrea E. Identification of a 3 kb Alu-mediated BRCA-1 gene rearrangement in two breast/ovarian cancer families. Oncogene. 18:1999;4160-4165.
16. Sleddens H.F., Oostra B.A., Brinkmann A.O., Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res. 20:1992;1427.